TIRAP Recombinant Antibody, PE-Cy5.5 Conjugated
Product Specifications
Background
Adapter involved in TLR2, TLR4 and RAGE signaling pathways in the innate immune response. Acts via IRAK2 and TRAF-6, leading to the activation of NF-kappa-B, MAPK1, MAPK3 and JNK, and resulting in cytokine secretion and the inflammatory response. Positively regulates the production of TNF-alpha (TNF) and interleukin-6 (IL6) .
Synonyms
MAL; Wyatt.
Gene ID
114609
Swiss Prot
P58753
Cellular Locus
Cytoplasm
Host
Rabbit
Cross Reactivity
Human, Mouse, Rat
Target
TIRAP
Clonality
Recombinant
Isotype
IgG
Conjugation
PE-Cy5.5
Source
KLH conjugated synthetic peptide derived from human TIRAP
Applications
WB
Purification
Purified by Protein A.
Excitation Emission
488nm/694nm
Concentration
Lot dependent
Dilution
WB (1:300-5000)
Buffer
Aqueous buffered solution containing 0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Modification
Unmodified
Storage Conditions
Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
Gene ID URL
114609
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS6496806-01 0.2 mL
RANKL, NT (Tumor Necrosis Factor Ligand Superfamily Member 11, Receptor Activator Of Nuclear Factor kappa-B Ligand, TNFSF11, TNF-related Activation-induced Cytokine, TRANCE, Tumor Necrosis Factor Ligand Superfamily Member 11, Soluble Form, Tumor Necrosis
Sign In for Pricing
View Details MBS6496806-02 5x 0.2 mL
RANKL, NT (Tumor Necrosis Factor Ligand Superfamily Member 11, Receptor Activator Of Nuclear Factor kappa-B Ligand, TNFSF11, TNF-related Activation-induced Cytokine, TRANCE, Tumor Necrosis Factor Ligand Superfamily Member 11, Soluble Form, Tumor Necrosis
Sign In for Pricing
View Details 